Alewijnse AE and Michel MC |
Sphingosine-1-phosphate and sphingosylphosphorylcholine: two of a kind? |
2006 |
Br. J. Pharmacol. |
pmid:16402045
|
Jeon ES et al. |
Sphingosylphosphorylcholine induces proliferation of human adipose tissue-derived mesenchymal stem cells via activation of JNK. |
2006 |
J. Lipid Res. |
pmid:16339111
|
Urs AN et al. |
Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1. |
2006 |
Endocrinology |
pmid:16887917
|
Fujiwaki T et al. |
Quantitative evaluation of sphingolipids using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to cardiac valves from a patient with Fabry disease. |
2006 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:16431168
|
|
Retraction. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. |
2006 |
Nat. Cell Biol. |
pmid:16508674
|
Katayama T et al. |
Blebbistatin inhibits sphingosylphosphorylcholine-induced contraction of collagen-gel fiber populated by vascular smooth-muscle cells. |
2006 |
J. Pharmacol. Sci. |
pmid:17072099
|
Li S et al. |
Intracellular signal transduction for migration and actin remodeling in vascular smooth muscle cells after sphingosylphosphorylcholine stimulation. |
2006 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:16899767
|
Jeon ES et al. |
Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism. |
2006 |
J. Cell. Sci. |
pmid:17105765
|
Ryu SK et al. |
Augmented sphingosylphosphorylcholine-induced Ca2+-sensitization of mesenteric artery contraction in spontaneously hypertensive rat. |
2006 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:16521007
|
Hemmings DG |
Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine. |
2006 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:16570136
|
Jin Y et al. |
Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor. |
2005 |
Eur. J. Immunol. |
pmid:16078278
|
|
Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. |
2005 |
J. Biol. Chem. |
pmid:16498716
|
Kamanna VS et al. |
Bioactive lysophospholipids and mesangial cell intracellular signaling pathways: role in the pathobiology of kidney disease. |
2005 |
Histol. Histopathol. |
pmid:15736064
|
Sakagami H et al. |
Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family. |
2005 |
J. Biol. Chem. |
pmid:15788404
|
Mogi C et al. |
Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. |
2005 |
J. Pharmacol. Sci. |
pmid:16210776
|
Im DS |
Two ligands for a GPCR, proton vs lysolipid. |
2005 |
Acta Pharmacol. Sin. |
pmid:16297340
|
van Diggelen OP et al. |
A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrate. |
2005 |
J. Inherit. Metab. Dis. |
pmid:16151905
|
Schubert R |
Non-capacitative calcium entry--extension of the possibilities for calcium entry in vascular tissue. |
2005 |
Cardiovasc. Res. |
pmid:16111665
|
Kim KS et al. |
GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine. |
2005 |
FASEB J. |
pmid:15857892
|
Thomas GD et al. |
Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: activation of non-store-operated Ca2+ entry. |
2005 |
Cardiovasc. Res. |
pmid:15950201
|